AP9100338A0 - Solid dosage forms of almokalant and process for manufacture thereof - Google Patents

Solid dosage forms of almokalant and process for manufacture thereof

Info

Publication number
AP9100338A0
AP9100338A0 AP91/00338A AP9100338A AP9100338A0 AP 9100338 A0 AP9100338 A0 AP 9100338A0 AP 91/00338 A AP91/00338 A AP 91/00338A AP 9100338 A AP9100338 A AP 9100338A AP 9100338 A0 AP9100338 A0 AP 9100338A0
Authority
AP
ARIPO
Prior art keywords
almokalant
manufacture
dosage forms
solid dosage
solid
Prior art date
Application number
AP91/00338A
Other versions
AP258A (en
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of AP9100338A0 publication Critical patent/AP9100338A0/en
Application granted granted Critical
Publication of AP258A publication Critical patent/AP258A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
APAP/P/1991/000338A 1990-12-07 1991-12-02 Solid dosage forms of almokalant and processes for manufacture thereof. AP258A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003902A SE9003902D0 (en) 1990-12-07 1990-12-07 SOLID DOSAGE FORMS OF A DRUG

Publications (2)

Publication Number Publication Date
AP9100338A0 true AP9100338A0 (en) 1992-01-31
AP258A AP258A (en) 1993-06-03

Family

ID=20381121

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1991/000338A AP258A (en) 1990-12-07 1991-12-02 Solid dosage forms of almokalant and processes for manufacture thereof.

Country Status (26)

Country Link
EP (1) EP0560821A1 (en)
JP (1) JPH06503312A (en)
CN (1) CN1063039A (en)
AP (1) AP258A (en)
AU (1) AU8930791A (en)
BG (1) BG97851A (en)
CA (1) CA2097178A1 (en)
CZ (1) CZ103793A3 (en)
FI (1) FI932554A (en)
HU (1) HUT64217A (en)
IE (1) IE914137A1 (en)
IL (1) IL100150A0 (en)
IS (1) IS3788A7 (en)
LT (1) LTIP1717A (en)
MA (1) MA22355A1 (en)
MX (1) MX9102325A (en)
MY (1) MY106776A (en)
NZ (1) NZ240731A (en)
PT (1) PT99719A (en)
SE (1) SE9003902D0 (en)
SK (1) SK55693A3 (en)
TN (1) TNSN91117A1 (en)
TW (1) TW215057B (en)
WO (1) WO1992010172A1 (en)
YU (1) YU186891A (en)
ZA (1) ZA919264B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19602757A1 (en) 1996-01-26 1997-07-31 Boehringer Mannheim Gmbh Solid instant release dosage forms and processes for their manufacture
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
JP4504467B2 (en) * 1998-07-30 2010-07-14 佐藤製薬株式会社 Orally disintegrating tablets
JP7426685B2 (en) * 2018-06-14 2024-02-02 株式会社東洋新薬 tablet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8705150D0 (en) * 1987-12-23 1987-12-23 Haessle Ab NOVEL ANTIARRHYTHMIC AGENTS
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
SE8902236D0 (en) * 1989-06-20 1989-06-20 Haessle Ab NOVEL POLYSTYRENESULPHONATE

Also Published As

Publication number Publication date
FI932554A (en) 1993-06-08
MY106776A (en) 1995-07-31
NZ240731A (en) 1993-10-26
EP0560821A1 (en) 1993-09-22
ZA919264B (en) 1992-08-26
PT99719A (en) 1992-10-30
MX9102325A (en) 1992-06-01
HU9301670D0 (en) 1993-09-28
SE9003902D0 (en) 1990-12-07
SK55693A3 (en) 1993-10-06
LTIP1717A (en) 1995-07-25
CN1063039A (en) 1992-07-29
TNSN91117A1 (en) 1992-10-25
JPH06503312A (en) 1994-04-14
HUT64217A (en) 1993-12-28
AP258A (en) 1993-06-03
YU186891A (en) 1994-04-05
MA22355A1 (en) 1992-07-01
TW215057B (en) 1993-10-21
WO1992010172A1 (en) 1992-06-25
CZ103793A3 (en) 1994-02-16
BG97851A (en) 1994-04-29
IS3788A7 (en) 1992-06-08
IL100150A0 (en) 1992-08-18
FI932554A0 (en) 1993-06-04
IE914137A1 (en) 1992-06-17
AU8930791A (en) 1992-07-08
CA2097178A1 (en) 1992-06-08

Similar Documents

Publication Publication Date Title
GB2189150B (en) Prosthesis and process for its manufacture
HU9303111D0 (en) Compounds causing decrease of serum- cholesterin - level and process for productiion thereof
HK105196A (en) Processing of tobacco leaves
GB2230278B (en) Filter material and method of manufacture
IL92681A0 (en) Process and intermediates for the preparation of 4-phenylpiperidines
YU236989A (en) Derivatives of 2-iminobenzothiazoline and process for obtaining thereof
GB9203206D0 (en) Treatment of particulate material
YU34189A (en) Process for obtaining antihipercholesterole tetrazolic compounds and their intermediers
EP0423526A3 (en) Process for the preparation of triethylenediamine and piperazine
EP0472422A3 (en) Oligohexafluoropropylene compounds and methods of making them
EP0459465A3 (en) Hiv-protease inhibitors and process for their preparation
AP9100338A0 (en) Solid dosage forms of almokalant and process for manufacture thereof
ZA911927B (en) Labdanes and process for their preparation
EG18954A (en) New bronchospasmolytic compounds and process for their preparation
EP0423686A3 (en) Silacyclobutanes and process for preparation
CS270091A3 (en) Cement of spherical-silicate type and process for preparing thereof
HUT67274A (en) Process for producing of tetrahydroindenoindoles and farmaceutical composition comprising them
ZA921040B (en) Process for the preparation of 4-alkylsulfonyl-1-alkyl-2-chlorobenzenes and similar compounds
EP0384692A3 (en) Charge-coupled device and process of fabrication thereof
GB2249790B (en) Method for preparation of organo-tellurium and selenium compounds
EP0438248A3 (en) Preparation process of toner
HU900145D0 (en) Process for preparation of complex forming substances
EP0427942A3 (en) Process for the preparation of s-triazine-sulfenimides and their use
GB2145722B (en) Process for the preparation of 6-demethyl-6-deoxy-6-methylene-5-oxytetracyclin and the 11a-chloro-derivative thereof
EP0408495A3 (en) Substituted tetrachalcogen fulvalenes and process for their preparation